Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: Mechanism of neuron death

Brain Research

Volumn 816, Issue 2, 1999, Pages 633-637

  Burke, William J ^a   Li, Shu Wen ^a   Schmitt, Catherine A ^a   Xia, Ping ^a   Chung, Hyung D ^a   Gillespie, Kathleen N ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

3,4 Dihydroxyphenylglycolaldehyde; Alzheimer's disease; Locus ceruleus; Neuron death; Neurotoxin

Indexed keywords

3,4 DIHYDROXYPHENYLGLYCOLALDEHYDE; ALDEHYDE DERIVATIVE; NORADRENALIN DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LOCUS CERULEUS; MALE; NERVE CELL DEGENERATION; NEUROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL;

AGED; ALDEHYDES; ALZHEIMER DISEASE; CELL COUNT; CELL DEATH; FEMALE; HUMANS; LOCUS COERULEUS; MALE; MONOAMINE OXIDASE; NEURONS; NEUROTOXINS; NOREPINEPHRINE;

EID: 0345518014     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01211-6     Document Type: Article

References (43)

1. Aunis D., Miras-Portugal M.-T., Mandel R. Bovine adrenal medullary dopamine β-hydroxylase: purification by affinity chromatography, kinetic studies and presence of essential histidyl residues. Biophys. Acta. 327:1973;313-327.
2. Busciglio J., Lorenzo A., Yeh J., Yanker B. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:1995;879-888.
3. Blaschko H. Amine oxidase and amine metabolism. Pharmacol. Rev. 4:1952;415-453.
4. Bondareff W., Mountjoy C.D., Roth M. Loss of neurons of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology. 32:1982;164-168.
5. Burke W.J., Davis J.W., Joh T.H., Reis D.J., Horenstein S., Bhagat B.D. The effect of epinephrine on phenylethanolamine N-methyltransferase in cultured explants of adrenal medulla. Endocrinology. 103:1978;358-367.
6. Burke W.J., Chung H.D., Huang J.S., Huang S.S., Haring J.H., Strong R., Marshall G.L., Joh T.H. Evidence for retrograde degeneration of epinephrine neurons in Alzheimer's disease. Ann. Neurol. 24:1988;532-536.
7. Burke W.J., Mattammal M.B., Marshall G.L., Chung H.D. Detection of 3,4-dihydroxyphenylglycolaldehyde in human brain by high-performance liquid chromatography. Anal. Biochem. 180:1989;79-84.
8. Burke W.J., Chung H.D., Marshall G.L., Gillespie K.N., Joh T.H. Evidence for decreased transport of PNMT protein in advanced Alzheimer's disease. J. Am. Geriatr. Soc. 38:1990;1275-1282.
9. Burke W.J., Park D.H., Chung H.D., Marshall G.L., Haring J.H., Joh T.H. Evidence for decreased transport of tryptophan hydroxylase in Alzheimer's disease. Brain Res. 537:1990;83-87.
10. Burke W.J., Galvin N.J., Chung H.D., Stoff S.A., Gillespie K.N., Cataldo A.M., Nixon R.A. Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease. Brain Res. 661:1994;35-42.
11. Burke W.J., Schmitt C.A., Li S.W., Gillespie K.N., Park D.H., Joh T.H. Measurement of enzyme activity, protein, mRNA and metabolites in small samples. Anal. Biochem. 230:1995;345-348.
12. Burke W.J., Schmitt C.A., Gillespie K.N., Li S.W. Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells. Brain Res. 722:1996;232-235.
13. Burke W.J., Schmitt C.A., Miller C., Li S.W., Barg J., Kristal B.S., Yu B.P. Mechanism of toxicity of 3,4-dihydroxyphenylglycolaldehyde in differentiated PC-12 cells: a model for adrenergic neuronal death in Alzheimer's disease. Neurology. 46:1996;A265.
14. Burke W.J., Schmitt C.A., Miller C., Li S.W. Norepinephrine transmitter metabolite induces apoptosis in differentiated rat pheochromocytoma cells. Brain Res. 760:1997;290-293.
15. Burke W.J., Kristal B.S., Yu B.P., Li S.W., Lin T.-S. Norepinephrine transmitter metabolite generates free radicals and activates mitochondrial permeability transition: a mechanism for DOPEGAL-induced apoptosis. Brain Res. 787:1998;328-332.
16. G. Cohen, Oxygen radicals and Parkinson's disease, in: B. Halliwell (Ed.), Oxygen Radicals and Tissue Injury, Federation of American Societies for Experimental Biology, Bethesda (1988) pp. 130-135.
17. Creveling C., Daly J., Witkop B., Udenfriend S. Substrates and inhibitors of dopamine-β-oxidase. Biochem. Biophys. Acta. 64:1962;125-134.
18. Goate A. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 353:1991;704-706.
19. Hardy J., Adolfsson R., Alafuzoff R., Bucht G., Marcusson J., Nyberg R., Perdahl E., Wester P., Winblad B. Transmitter deficits in Alzheimer's disease. Neurochem. Int. 7:1985;545-563.
20. Green L.A. Establishment of noradrenergic clonal lines of rat pheochromocytoma cells which respond to nerve cell growth factor. Proc. Natl. Acad. Sci. 73:1976;2424-2429.
21. K. Iqbal, T. Zaidi, G.Y. Wen, I. Grundke-Iqbal, H.M. Wisniewski, Defective brain microtubule assembly in Alzheimer's disease, Lancet, i(1986) 421-426.
22. Heintz N., Zoghbi H. Alpha-synuclein - a link between Parkinson and Alzheimer diseases. Nature Genetics. 16:1997;325-327.
23. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokoshi M., Mizuno Y., Shimizu N. Mutations in parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608.
24. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
25. Kristal B.S., Park B.K., Yu B.P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271:1996;6033-6038.
26. Kristal B.S., Dubinsky J.M. Mitochondrial permeability transition in the central nervous system: induction by calcium cycling dependent and independent pathways. J. Neurochem. 69:1997;524-538.
27. Lassman H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:1995;35-41.
28. Lee V.M., Balin B.J., Otur S.L., Trojanowski J.D. A68: a major subunit of paired helical filaments and derivative of forms of normal tau. Science. 251:1991;675-678.
29. Li S.W., Elliott W.H., Burke W.J. Synthesis of a biochemically important aldehyde, 3,4-dihydroxyphenylglycolaldehyde. Bioorg. Chem. 22:1994;337-342.
30. Li S.W., Spaziano V.T., Elliott W.H., Burke W.J. Synthesis and use of deuterated 3,4-dihydroxyphenylglycolaldehyde as an internal standard for determination of DOPEGAL in brain tissue by gas chromatography-mass spectrometry. Bioorg. Chem. 24:1996;169-177.
31. Markey J.P., Johanessen J.N., Chiveh C.C., Burne S.S., Herkenham M.A. Intraneuronal generation of pyridinium metabolite may cause drug-induced Parkinsonism. Nature. 311:1984;464-467.
32. Marsden C.A., Broch O.J., Guldberg H.C. Effect of nigral and raphe lesion on the catechol-O-methyltransferase and monoamine oxidase activities in the rat striatum. Eur. J. Pharmacol. 19:1972;35-42.
33. Roush W. Protein studies try to puzzle out Alzheimer's tangles. Science. 267:1995;793-794.
34. Schinder A.F., Olson E.C., Spitzer N.C., Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16:1996;6125-6133.
35. Singer R.H. Triplet-repeat transcripts: a role for RNA in disease. Science. 280:1998;696-697.
36. Sperk G., Galhaup I., Schlogl E., Hortnagl H., Hornykiewicz O. A sensitive and reliable assay for dopamine β-hydroxylase in tissue. J. Neurochem. 35:1980;972-976.
37. Strittmatter W.J., Weisgraber K.H., Goedert M., Saunders A.M., Huang D., Corder E.H., Dong L.-M., Jakes R., Alberts M.J., Gilbert J.R., Han S.-H., Hulette C., Einstein G., Schmechl D.E., Pericak-Vance M.A., Roses A.D. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125:1994;163-171.
38. Susin S.-A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331-1341.
39. Swanson L.W. The locus ceruleus: a cytoarchitectonic, Golgi and immunohistochemical study in the albino rat. Brain Res. 110:1976;39-56.
40. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1994;1456-1462.
41. Younkin S.G., Goodridge B., Katz J., Lockett G., Nafziger D., Usiak M.F., Younkin L.H. Molecular forms of acetylcholine esterase in Alzheimer's disease. Fed. Proc. 45:1988;2982-2988.
42. White R.J., Reynolds I.J. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal to excitotoxic exposure. J. Neurosci. 16:1996;5688-5697.
43. Zoratti M., Szabo I. The mitochondrial permeability transition. Biochem. Biophys. Acta. 1241:1995;139-176.